Welcome to our dedicated page for V2X SEC filings (Ticker: VVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
V2X, Inc. SEC filings document an NYSE-listed government mission-solutions contractor with common stock registered under the symbol VVX. The company's 8-K filings report results of operations, financial condition, fiscal guidance, and material corporate events, including leadership appointments, board composition changes, and compensation arrangements.
V2X proxy materials cover shareholder voting matters, director elections, board committee assignments, executive compensation, equity awards, and corporate governance principles. The filings also record capital-structure details for the company's common stock and governance changes connected to board service requirements and shareholder agreement provisions.
V2X, Inc. director Nicole B. Theophilus reported equity compensation activity involving common stock and restricted stock units (RSUs). On May 7, 2026, she exercised 838 RSUs, which converted into an equal number of V2X common shares, leaving her with 838 common shares directly held after the transaction.
She also received a new award of 2,188 RSUs that will convert into V2X common stock on a one-for-one basis. According to the award terms, these RSUs are scheduled to vest on the earlier of the company’s 2027 annual shareholders’ meeting date or May 7, 2027. A prior RSU grant referenced in the filing was granted on January 9, 2026 and fully vested on May 7, 2026.
V2X, Inc. director Ross Niebergall reported equity compensation changes. On May 7, 2026, 838 previously granted restricted stock units (RSUs) converted into 838 shares of V2X common stock on a one-for-one basis, which he now holds directly.
On the same date, Niebergall received a new award of 2,188 RSUs. According to the disclosure, these RSUs are scheduled to vest on the earlier of the V2X 2027 Annual Shareholders' Meeting date and May 7, 2027. After these transactions, the filing shows 838 common shares held directly and 2,188 RSUs outstanding as equity-based compensation.
V2X, Inc. director Mary L. Howell reported routine equity compensation activity. She exercised previously granted restricted stock units (RSUs) to acquire 4,487 shares of V2X common stock at a price of $0.00 per share, reflecting conversion of vested awards into stock on a one-for-one basis.
She also received a new grant of 3,017 RSUs, which are scheduled to vest on the earlier of the V2X 2027 Annual Shareholders' Meeting and May 7, 2027. Following these transactions, she holds 4,487 V2X shares directly and 40,373 shares indirectly through the Mary L. Howell Rev Trust, with no open-market purchases or sales disclosed in this filing.
V2X, Inc. SVP and CHRO Yeshoalul Melon reported routine equity compensation activity involving restricted stock units (RSUs). On May 8, 2026, 1,545 RSUs converted into an equal number of V2X common shares, reflecting the first vesting installment of a prior RSU grant that vests in three equal annual installments beginning on May 8, 2026.
To cover tax obligations, 466 common shares were disposed of through a tax-withholding transaction at $71.56 per share, rather than an open-market sale. After these events, Melon directly held 1,079 shares of V2X common stock. The RSUs convert to common stock on a one-for-one basis as they vest.
V2X, Inc. disclosed that it entered into an underwriting agreement with Vertex Aerospace Holdco LLC and Morgan Stanley & Co. LLC for a public secondary offering of 2,004,569 shares of V2X common stock. The transaction was conducted under an existing shelf registration statement and related prospectus supplement.
The company did not sell any shares and will not receive proceeds, as all shares were sold by the selling shareholder. After the offering, the selling shareholder no longer owns V2X common stock, while an affiliated entity continues to beneficially own 375,420 shares, described as approximately 1.2% of outstanding common stock.
V2X is registering 2,004,569 shares of common stock for resale by a selling shareholder.
The prospectus supplement states the company will receive no proceeds from these sales; the underwriter agreed to purchase the shares from the selling shareholder at $73.91 per share (public offering price listed as $74.35). Shares outstanding were 31,310,209 as of April 3, 2026, and delivery of the shares is expected on or about May 11, 2026.
V2X, Inc. reported results from its 2026 Annual Meeting of Shareholders and a planned board change. Long‑time director Steven L. Waechter, age 76, ended his term as a Class III director in line with Corporate Governance Principles that limit nominees to age 75 at the meeting date. The company stated his departure did not involve any disagreement over operations, policies, or practices. The Board size was reduced from ten to nine members, eliminating one Class III seat, and committee roles formerly held by Mr. Waechter will be filled by Gerard A. Fasano on the Compensation committee and Nicole B. Theophilus on the Nominating and Governance committee. Shareholders elected Class III directors Melvin F. Parker, Ross S. Niebergall, and Jeremy C. Wensinger, each receiving over 26.7 million "for" votes, ratified RSM US LLP as independent auditor for 2026 with 29,441,872 votes in favor, and approved on an advisory basis executive compensation for 2025 with 27,646,063 votes "for."
V2X Inc. ownership amendment: FMR LLC reports beneficial ownership of 3,742,265.81 shares of Common Stock, representing 12.0% of the class. The filing (Schedule 13G/A, Amendment No. 11) shows sole dispositive power of 3,742,265.81 shares and identifies Abigail P. Johnson as having sole dispositive power.
V2X, Inc. reported strong first quarter 2026 results with higher full-year guidance. Revenue reached $1.25 billion, up 23% year-over-year, as operating income rose to $44.1 million. Net income increased to $18.9 million, while adjusted net income grew 53% to $48.1 million.
Profitability and backlog improved alongside non-GAAP metrics. Adjusted EBITDA was $85.6 million with a 6.8% margin, and adjusted diluted EPS rose 55% to $1.53. Backlog hit a record $13.8 billion with a quarterly book-to-bill of about 3.2x, supported by roughly $4.1 billion in awards.
Guidance for 2026 was raised. V2X now targets revenue between $4.83 billion and $4.98 billion and adjusted EBITDA between $345 million and $360 million. The company also expects adjusted diluted EPS of $5.75–$6.15 and aims for a net leverage ratio below 2.0x by the end of 2026.
V2X, Inc. reported significantly stronger quarterly results, with revenue rising to $1.25 billion for the three months ended April 3, 2026, up 23% from $1.02 billion a year earlier. Growth was driven mainly by program ramp ups in global training and mission readiness, especially in the U.S. market.
Operating income increased to $44.1 million, up 29%, while net income more than doubled to $18.9 million from $8.1 million, as margins improved slightly despite higher selling, general and administrative costs. Backlog expanded to $13.8 billion, reflecting strong future revenue visibility, including $2.29 billion of funded backlog.
The company ended the quarter with $208.7 million in cash, cash equivalents and restricted cash and access to $479.0 million under its revolving credit facility. Long-term debt remained substantial but scheduled repayments and available liquidity support ongoing operations. V2X highlighted potential scope reductions on its LOGCAP V – Kuwait Task Order after June 2026, which could lower revenue from that contract, though the ultimate impact remains uncertain.